Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy

• Egile Nagusiak: Santarpia M (Egilea), Daffinà MG (Egilea), D'Aveni A (Egilea), Marabello G (Egilea), Liguori A (Egilea), Giovannetti E (Egilea), Karachaliou N (Egilea), Gonzalez Cao M (Egilea), Rosell R (Egilea), Altavilla G (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2017-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Mariacarmela Santarpia,1 Maria Grazia Daffinà,1 Alessandro D’Aveni,1 Grazia Marabello,1 Alessia Liguori,1 Elisa Giovannetti,2–4 Niki Karachaliou,5 Maria Gonzalez Cao,6 Rafael Rosell,7,8 Giuseppe Altavilla1 1Medical Oncology Unit, Department of Human Pathology “G. Barresi”, University of Messina, Mes...